Clinical Data Sells IVD Business to Support PGx Arm; Auditor Raises Solvency Doubt

Jun 20, 2007

NEW YORK (GenomeWeb News) — Clinical Data in fiscal 2007 sold its Vital Diagnostics business, an Australia-based IVD segment focused on the US market, for $1.5 million, the company said yesterday.

The company also divested its Rhode Island-based Clinical Data Sales & Service business for $7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Blame the Follicles

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Missed a Few

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

This Week in Cell

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Yep, Couple of Concerns There

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

Main menu